Taiwan Outcomes and Real-world Treatment Options for Chronic Obstructive Pulmonary Disease
Data Collection
Collected from past medical records and data - RetrospectiveChronic Disease+5
+ Lung Diseases
+ Lung Diseases, Obstructive
Cohort
Tracking disease incidence in order to identify risk factors and understand disease progression over time.Summary
Study start date: December 29, 2019
Actual date on which the first participant was enrolled.Study to collect the data on Chronic Obstructive Pulmonary Disease (COPD) patients who were administered with Long-Acting Beta-Agonist/ Long-Acting Muscarinic Antagonist (LABA/LAMA) (Fixed-dose Combination (FDC) or free combo) or LAMA treatment
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.1617 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Cohort
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.Over 40 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Inclusion Criteria: Patients who fulfil ALL the following criteria are included. 1. Patients who diagnosed with COPD who were prescribed with LABA/LABA (FDC or free combo) as a new initiation or switching from other therapy (i.e., single/dual/triple), or newly receiving LAMA treatment for 3 months at least prior to 30 June 2018 2. Male or female patients ≥ 40 years of age Exclusion Criteria: 1\. Patients who meet the following criterion are not included. * Patients with documented diagnosis of bronchial asthma, asthma-COPD overlap syndrome (ACOS), bronchiectasis, cystic fibrosis, or lung cancer
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.Study Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 12 locations
Ditmanson Medical Foundation Chia - Yi Christian Hospital
Chia YI City, TaiwanOpen Ditmanson Medical Foundation Chia - Yi Christian Hospital in Google MapsCGMH Chia YI
Chia YI City, TaiwanEda hospital
Kaohsiung City, TaiwanCGMH Kaohsiung
Kaohsiung City, Taiwan